Damodaran Equity Model

This tool is best used for growth companies

Use Your Own Alpha Vantage API Key // shared key (rate-limited)

// Stored in localStorage on this device only. Browser-direct fetch — your IP is the one seen by Alpha Vantage.

Valuation Context

Your Thesis // judgment inputs

No API gives you these. These inputs encode your view of where the company is going. Anchor on history, analyst consensus, and Damodaran's sector tables — the choice is yours. Damodaran data hub →

// fetch financials first, then generate (typically 30s–2 min; cached 1 week per ticker)

ⓘ How to set growth + duration

Growth rate = your forecast of annual revenue growth for the first phase. Anchor on:

  • The company's last 3 fiscal years of growth.
  • Analyst consensus on Yahoo Finance ("Analysis" tab) or stockanalysis.com.
  • Management's own guidance from the latest 10-K / 20-F / earnings call.

Duration = how long this rate holds before fading to terminal growth (≈ risk-free rate). Default 5y. Wide-moat firms (Visa, ASML, ServiceNow) justify 7–10y; commodity businesses 2–3y.

Rough benchmarks:

  • Mature consumer staples: 3–6%
  • Mature financial / utility: 4–7%
  • Healthy software: 15–30%
  • Hyper-growth IPO: 30–60%
ⓘ How long does R&D "pay back"?

How many years should past R&D spending be capitalized as an intangible asset before being fully amortized? Auto-prefilled from the matched sector.

Damodaran's defaults:

  • Software (rapid obsolescence): 3 years
  • Hardware / electronics: 5 years
  • Pharma / biotech (long approval): 10 years
  • Aerospace / defense: 10 years
Fair Value / Share
$0.00
Awaiting Data
Margin of Safety (20%)
$0.00
Target Buy Price
Cost of Capital (WACC)
0.00%
Levered Beta 0.00

Accounting vs. Economic Reality

GAAP Operating Income
$0m
Damodaran Adjusted EBIT
$0m
R&D / Leases Capitalized

10-Year Projected Free Cash Flow (FCFF)

IN MILLIONS USD

Live Data // API-fetched

Auto-populated from the API fetch at the top. Override only if the latest filing isn't yet indexed, or if you want to use a forward / normalized number.

Prior-Year R&D (For Asset Base) *recommended

// BLANK / NaN = assume flat at current (yields zero net EBIT adjustment). Explicit 0 is treated as 0.

Cost of Capital

ⓘ Where these come from

Beta (unlevered) = sector-level asset beta. Auto-set from the matched Damodaran industry. Override if you have a strong view.

Risk-Free Rate = 10Y government bond yield in the SAME currency the company reports in. Damodaran's rule: Rf must match the cash-flow currency, NOT the listing country. ADRs (ASML, BABA, MELI) report in their functional currency.

  • USD → US 10Y (≈ 4.4%) — FRED
  • EUR → German Bund 10Y (≈ 2.5%)
  • GBP → UK Gilt 10Y (≈ 4.2%)
  • JPY → JGB 10Y (≈ 1.1%)
  • SEK → Swedish 10Y (≈ 2.4%)
  • CHF → Swiss Confed. 10Y (≈ 0.8%)

Note: the calculator hardcodes terminal growth g = riskFreeRate (Damodaran's structural cap — no firm can grow faster than its currency's economy forever). There is no separate terminal-growth input on purpose.

Equity Risk Premium = expected stock-market return over Rf. Damodaran's monthly "implied ERP" is the standard, currently ≈ 4.5%. Damodaran's ERP / CRP page →

Country Risk Premium = added for non-US firms. 0% for US, ≈ 0.5–1% for Western Europe, higher for emerging markets.